Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00978757

Organisation Name: Hospital Italiano de Buenos Aires

Overal Status: Completed

Start Date: June 2001

Last Update: January 15, 2019

Lead Sponsor: Hospital Italiano de Buenos Aires

Brief Summary: The purpose of this study is to determine whether ketamine is effective to inhibit interleukin 6 synthesis in hepatic resections requiring temporary porto-arterial occlusion.

Conditions:
  • Hepatectomy


Total execution time in seconds: 0.20617699623108